Drawing for ULRICHEASYINJECT MAX 3M

USPTO serial 79142729

ULRICHEASYINJECT MAX 3M

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
ERVIN, INGA
Law office
TMO LAW OFFICE 111 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with ULRICHEASYINJECT MAX 3M?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
010Medical apparatus and instruments, namely injectors; injectors for contrast agents for use in computer tomography and magnetic resonance imaging; syringes for injections; pumps for medical purposes, namely pumps for contrast agents for administering contrast agents; pump hoses for injectors for contrast agents; patient hoses, namely injection hoses for intravenous injection; cannulae; injection needles; suture needles; medical containers for contrast agents; containers for medical wasteSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 30, 2017IRRHIRREGULARITY FROM IB EXAMINED BY MPU—
Nov 6, 2015IRFIIRREGULARITY ON FINAL DECISION RECEIVED FROM IB—
Oct 21, 2015FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 21, 2015FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 22, 2015OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 22, 2015OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Mar 21, 2015DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Mar 20, 2015DETHDEATH OF INTERNATIONAL REGISTRATION—
Oct 21, 2014MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 21, 2014ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 11, 2014RFNTREFUSAL PROCESSED BY IB—
Mar 24, 2014RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 24, 2014RFRRREFUSAL PROCESSED BY MPU—
Mar 22, 2014RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 21, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 13, 2014DOCKASSIGNED TO EXAMINER—
Feb 28, 2014MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 24, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 21, 2014REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance